{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Intensive+therapy&page=20", "query": { "intervention": "Intensive therapy", "page": 20 }, "page_size": 10 }, "pagination": { "page": 20, "page_size": 10, "total_count": 975, "total_pages": 98, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Intensive+therapy&page=21&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Intensive+therapy&page=19&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-25T18:39:37.305Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00016302", "title": "Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "T-cell Childhood Acute Lymphoblastic Leukemia", "Untreated Childhood Acute Lymphoblastic Leukemia" ], "interventions": [ { "name": "prednisone", "type": "DRUG" }, { "name": "vincristine sulfate", "type": "DRUG" }, { "name": "daunorubicin hydrochloride", "type": "DRUG" }, { "name": "asparaginase", "type": "DRUG" }, { "name": "methotrexate", "type": "DRUG" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "cytarabine", "type": "DRUG" }, { "name": "mercaptopurine", "type": "DRUG" }, { "name": "leucovorin calcium", "type": "DRUG" }, { "name": "dexamethasone", "type": "DRUG" }, { "name": "doxorubicin hydrochloride", "type": "DRUG" }, { "name": "thioguanine", "type": "DRUG" }, { "name": "radiation therapy", "type": "RADIATION" }, { "name": "nelarabine", "type": "DRUG" }, { "name": "pegaspargase", "type": "DRUG" }, { "name": "pharmacological study", "type": "OTHER" }, { "name": "laboratory biomarker analysis", "type": "OTHER" } ], "intervention_types": [ "DRUG", "RADIATION", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "21 Years", "sex": "ALL", "summary": "1 Year to 21 Years" }, "enrollment_count": 100, "start_date": "2001-04", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-01-16", "last_synced_at": "2026-10-25T18:39:37.305Z", "location_count": 1, "location_summary": "Arcadia, California", "locations": [ { "city": "Arcadia", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00016302" }, { "nct_id": "NCT07246603", "title": "Virtual Housecalls: Redesigning Pediatric Primary Care Adolescent Obesity Treatment", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Class I Obesity", "Pediatric Obesity" ], "interventions": [ { "name": "Virtual Housecalls", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Virginia Commonwealth University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Years", "maximum_age": "15 Years", "sex": "ALL", "summary": "12 Years to 15 Years" }, "enrollment_count": 500, "start_date": "2026-08-25", "completion_date": "2030-01-31", "has_results": false, "last_update_posted_date": "2026-08-26", "last_synced_at": "2026-10-25T18:39:37.305Z", "location_count": 1, "location_summary": "Henrico, Virginia", "locations": [ { "city": "Henrico", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT07246603" }, { "nct_id": "NCT00004905", "title": "Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Leukemia" ], "interventions": [ { "name": "filgrastim", "type": "BIOLOGICAL" }, { "name": "recombinant interferon alfa", "type": "BIOLOGICAL" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "cytarabine", "type": "DRUG" }, { "name": "etoposide", "type": "DRUG" }, { "name": "idarubicin", "type": "DRUG" }, { "name": "peripheral blood stem cell transplantation", "type": "PROCEDURE" }, { "name": "radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "PROCEDURE", "RADIATION" ], "sponsor": "Loyola University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": null, "start_date": "1999-10", "completion_date": "2004-09", "has_results": false, "last_update_posted_date": "2013-05-30", "last_synced_at": "2026-10-25T18:39:37.305Z", "location_count": 3, "location_summary": "Chicago, Illinois • Maywood, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Maywood", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00004905" }, { "nct_id": "NCT01432093", "title": "Intensive Glycemic Management and Outcomes Following Liver Transplantation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hospital Hyperglycemia", "Post-transplant Hyperglycemia" ], "interventions": [ { "name": "Intensive glycemic management", "type": "OTHER" }, { "name": "Conventional management", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 270, "start_date": "2011-10", "completion_date": "2013-07", "has_results": false, "last_update_posted_date": "2013-11-13", "last_synced_at": "2026-10-25T18:39:37.305Z", "location_count": 1, "location_summary": "Jacksonville, Florida", "locations": [ { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01432093" }, { "nct_id": "NCT04748848", "title": "A Safety, Tolerability and Preliminary Efficacy Study of CC-90011 in Combination With Venetoclax and Azacitidine in R/R Acute Myeloid Leukemia and Treatment-naïve Participants Not Eligible for Intensive Therapy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Leukemia, Myeloid" ], "interventions": [ { "name": "CC-90011", "type": "DRUG" }, { "name": "Venetoclax", "type": "DRUG" }, { "name": "Azacitidine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Celgene", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1, "start_date": "2021-10-14", "completion_date": "2022-03-09", "has_results": false, "last_update_posted_date": "2023-03-02", "last_synced_at": "2026-10-25T18:39:37.305Z", "location_count": 11, "location_summary": "Duarte, California • New Haven, Connecticut • Miami, Florida + 8 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Miami", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04748848" }, { "nct_id": "NCT06640478", "title": "A 12-week Pilot Nutrition Intervention for Children With New Diagnosis of Stage 3 Type 1 Diabetes (T1D)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Type 1 Diabetes" ], "interventions": [ { "name": "NUTRI-Beta Counseling", "type": "OTHER" }, { "name": "Standard dietary counseling", "type": "DIETARY_SUPPLEMENT" }, { "name": "Free weekly produce foods", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "OTHER", "DIETARY_SUPPLEMENT" ], "sponsor": "Milton S. Hershey Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 20, "start_date": "2024-11-20", "completion_date": "2026-06-30", "has_results": false, "last_update_posted_date": "2026-10-05", "last_synced_at": "2026-10-25T18:39:37.305Z", "location_count": 2, "location_summary": "Hershey, Pennsylvania", "locations": [ { "city": "Hershey", "state": "Pennsylvania" }, { "city": "Hershey", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06640478" }, { "nct_id": "NCT06433648", "title": "Understanding How Powered Componentry Impacts K2-Level Transfemoral Amputee Gait", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Amputation", "Amputation, Traumatic", "Amputation of Knee", "Amputation; Traumatic, Limb" ], "interventions": [ { "name": "Ottobock CLeg4 + Ottobock foot", "type": "DEVICE" }, { "name": "SRALAB Hybrid Knee + Polycentric Ankle", "type": "DEVICE" }, { "name": "SRALAB Hybrid Knee + Passive Ankle", "type": "DEVICE" }, { "name": "Ottobock CLeg 4 + Polycentric Ankle", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Shirley Ryan AbilityLab", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "95 Years", "sex": "ALL", "summary": "18 Years to 95 Years" }, "enrollment_count": 20, "start_date": "2023-05-01", "completion_date": "2029-06-30", "has_results": false, "last_update_posted_date": "2024-05-30", "last_synced_at": "2026-10-25T18:39:37.305Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT06433648" }, { "nct_id": "NCT01603784", "title": "Combining Exercise and Cognitive Training to Improve Everyday Function", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Effect of Exercise on Cognitive Function" ], "interventions": [ { "name": "Intensive Exercise", "type": "BEHAVIORAL" }, { "name": "Home Exercise", "type": "BEHAVIORAL" }, { "name": "Cognitive Training", "type": "BEHAVIORAL" }, { "name": "Health Education", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "55 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "55 Years to 75 Years" }, "enrollment_count": 96, "start_date": "2010-03", "completion_date": "2013-06", "has_results": false, "last_update_posted_date": "2014-09-03", "last_synced_at": "2026-10-25T18:39:37.305Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT01603784" }, { "nct_id": "NCT07537413", "title": "Ceftriaxone Dosage for Non-Critical Community-Acquired Pneumonia", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Community Acquired Pneumonia (CAP)" ], "interventions": [ { "name": "Ceftriaxone 1 gram daily", "type": "DRUG" }, { "name": "Ceftriaxone 2 grams daily", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Maryland, Baltimore", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 900, "start_date": "2026-09-01", "completion_date": "2028-02-28", "has_results": false, "last_update_posted_date": "2026-09-14", "last_synced_at": "2026-10-25T18:39:37.305Z", "location_count": 4, "location_summary": "Baltimore, Maryland • Glen Burnie, Maryland • Towson, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Glen Burnie", "state": "Maryland" }, { "city": "Towson", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT07537413" }, { "nct_id": "NCT04051996", "title": "GLAD-AML - Glasdegib (Pf-04449913) With Two Standard Decitabine Regimens for Older Patients With Poor-risk Acute Myeloid Leukemia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "ACUTE MYELOID LEUKEMIA" ], "interventions": [ { "name": "Glasdegib", "type": "DRUG" }, { "name": "Decitabine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1, "start_date": "2019-12-06", "completion_date": "2020-06-09", "has_results": true, "last_update_posted_date": "2021-10-15", "last_synced_at": "2026-10-25T18:39:37.305Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT04051996" } ] }